Information for Semaglutide
Page information·measured at build time
Technical and provenance information about Semaglutide. All figures on this page are measured from the emitted page rather than declared.
Basic information
| Display title | Semaglutide |
|---|---|
| Default sort key | Semaglutide |
| Namespace | Article (main) |
| Page kind | Compound |
| Page length (source, bytes) | 10,355 |
| Rendered word count | 1,232 |
| Internal wiki links on the page | 41 |
| Defined citations | 6 |
| Top-level sections | 5 |
| Subsections | 0 |
| Tables | 1 |
| Figures | 0 |
| Infobox | Yes — compound |
| Maintenance banners | medical |
| Indexing by robots | Allowed |
Edit history
| Page creator | CrudePeptidePearl |
|---|---|
| Date of page creation | 11 June 2024 |
| Latest editor | DefinedTermDov |
| Date of latest edit | 12 July 2026 |
| Total number of edits | 41 |
| Total number of distinct authors | 33 |
| Minor edits | 16 |
| Automated (bot) edits | 5 |
| Recent number of edits (last 90 days) | 3 |
| Talk page posts | 14 |
Principal authors
| Editor | Edits | Share | Declared focus |
|---|---|---|---|
| StubSorterBot | 2 | 4.9% | categorisation and navigation |
| SemaglutideSasha | 2 | 4.9% | GLP-1 receptor agonists and related compounds |
| ComparisonCato | 2 | 4.9% | GLP-1 receptor agonists and related compounds |
| Chromatokid | 2 | 4.9% | analytical chemistry and chromatography |
| OrforglipronOona | 2 | 4.9% | GLP-1 receptor agonists and related compounds |
| SecretagogueSol | 2 | 4.9% | research peptides |
| ArchiveBot | 2 | 4.9% | policy, notability and deletion |
| LiraLotte | 2 | 4.9% | GLP-1 receptor agonists and related compounds |
| CrudePeptidePearl | 1 | 2.4% | peptide synthesis and supply chain |
| MazdutideMads | 1 | 2.4% | GLP-1 receptor agonists and related compounds |
| FlowTrialFraser | 1 | 2.4% | clinical trials and evidence appraisal |
| BatchNumberBede | 1 | 2.4% | third-party testing and certificates of analysis |
Category membership
- Category:GLP-1 receptor agonists — 8 member pages
- Category:Peptide drugs — 17 member pages
- Category:Pharmacokinetics — 12 member pages
- Category:Articles describing unapproved compounds — 21 member pages
- Category:Articles describing unapproved compounds (maintenance)